Case study

Optimising formulation to improve solubility ready for Phase III

OSD

A company developing a new chemical entity (NCE) for the treatment of auto-immune disease entrusted Recipharm with clinical batch manufacture of a tablet formulation for the compound.

To read our case study please complete your details below:

First Name

Last Name

Company

Where are you based?

State/Province

I agree that Recipharm registers the above information and gives me information about services and products via email. Read more about our Privacy Policy

Hidden OSD

Hidden SFF

Hidden ADS

Hidden BU not set